{"DataElement":{"publicId":"7669660","version":"1","preferredName":"Ancillary Study Mutational Analysis Testing Method Text","preferredDefinition":"A textual description of the specific molecular analysis method used to detect and identify mutations provided as part of the secondary study data.","longName":"7669659v1.0:6784451v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7669659","version":"1","preferredName":"Ancillary Study Mutational Analysis Testing Method","preferredDefinition":"A study that is secondary to another study._A request to enter the specific molecular analysis method used to detect and identify mutations in that section of the form.","longName":"7052721v1.0:7669657v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"7052721","version":"1","preferredName":"Ancillary Study","preferredDefinition":"A study that is secondary to another study.","longName":"C16041","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ancillary Study","conceptCode":"C16041","definition":"A study that is secondary to another study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"973C983C-51FC-1152-E053-F662850AE6FF","latestVersionIndicator":"Yes","beginDate":"2019-11-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-13","modifiedBy":"ONEDATA","dateModified":"2019-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7669657","version":"1","preferredName":"Specify Mutation Analysis Method","preferredDefinition":"A request to enter the specific molecular analysis method used to detect and identify mutations in that section of the form.","longName":"C158846","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify Mutation Analysis Method","conceptCode":"C158846","definition":"A request to enter the specific molecular analysis method used to detect and identify mutations in that section of the form.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2D7FFC6-F596-2C62-E053-4EBD850AEAEE","latestVersionIndicator":"Yes","beginDate":"2021-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-05-21","modifiedBy":"ONEDATA","dateModified":"2021-05-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"C2D7FFC6-F5A7-2C62-E053-4EBD850AEAEE","latestVersionIndicator":"Yes","beginDate":"2021-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-05-21","modifiedBy":"KNABLEJ","dateModified":"2021-05-21","changeDescription":"5/21/21 jk created for Phase 3 Baseline CRFs, generalized for multiple genes.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6784451","version":"1","preferredName":"255 Character Text","preferredDefinition":"The words of something written.","longName":"6784451v1.0","context":"OCCPR","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"255","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234203","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F89B-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8BA00B33-81DA-0AB8-E053-F662850A521F","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-18","modifiedBy":"KNABLEJ","dateModified":"2020-06-23","changeDescription":"11/10/19 jk Released per CPTAC SME (Linda) for Medical History CRF.  6-18-19 tt created for CPTAC Medical History CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"10000348","version":"1","longName":"Melanoma","context":"OCCPR"},{"publicId":"7634324","version":"1","longName":"CM Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Mutational Analysis Testing M","type":"Preferred Question Text","description":"Mutational Analysis Testing Method","url":null,"context":"OCCPR"},{"name":"CPTAC-Phase-3-CM-BRAF","type":"Alternate Question Text","description":"BRAF Mutational Analysis Testing Method","url":null,"context":"OCCPR"},{"name":"CPTAC-Phase-3-CM-NRAS","type":"Alternate Question Text","description":"NRAS Mutational Analysis Testing Method","url":null,"context":"OCCPR"},{"name":"CPTAC-Phase-3-CM-KIT","type":"Alternate Question Text","description":"KIT Mutational Analysis Testing Method","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"C2D80E55-1643-3B03-E053-4EBD850AF5DC","latestVersionIndicator":"Yes","beginDate":"2021-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-05-21","modifiedBy":"KNABLEJ","dateModified":"2021-05-24","changeDescription":"5/24/21 jk upd sys gen def.  5/19/21 jk created for Phase 3 Baseline CRFs, AQT for gene specific questions.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}